These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22421615)

  • 21. On the way towards the eradication of chronic hepatitis B.
    Ren H
    J Viral Hepat; 2019 Jul; 26 Suppl 1():3-4. PubMed ID: 31380587
    [No Abstract]   [Full Text] [Related]  

  • 22. Do we need better hepatitis B vaccines?
    Gerlich WH
    Indian J Med Res; 2017 Apr; 145(4):414-419. PubMed ID: 28862172
    [No Abstract]   [Full Text] [Related]  

  • 23. [Screening for hepatitis B].
    Krogsgaard K
    Ugeskr Laeger; 2002 Jan; 164(2):159-62. PubMed ID: 11831078
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis B virus: is a cure possible?
    Zeisel MB; Baumert TF
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1129-30. PubMed ID: 27347775
    [No Abstract]   [Full Text] [Related]  

  • 25. High prevalence of hepatitis B virus among female sex workers in Nigeria.
    Forbi JC; Onyemauwa N; Gyar SD; Oyeleye AO; Entonu P; Agwale SM
    Rev Inst Med Trop Sao Paulo; 2008; 50(4):219-21. PubMed ID: 18813761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus.
    Kafatos G; Anastassopoulou C; Nardone A; Andrews N; Barbara C; Boot HJ; Butur D; Davidkin I; Gelb D; Griskevicius A; Hesketh L; Icardi G; Jones L; Kra-Oz Z; Miller E; Mossong J; Nemecek V; de Ory F; Sobotová Z; Thierfelder W; Van Damme P; Hatzakis A
    J Viral Hepat; 2007 Apr; 14(4):260-8. PubMed ID: 17381718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination against hepatitis B among prisoners in Iran: accelerated vs. classic vaccination.
    Asli AA; Moghadami M; Zamiri N; Tolide-Ei HR; Heydari ST; Alavian SM; Lankarani KB
    Health Policy; 2011 May; 100(2-3):297-304. PubMed ID: 21269722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Persistence of immunity after hepatitis B vaccination].
    Madaliński K
    Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perinatal transmission of hepatitis B virus infection.
    Erdem G; Tekinalp G; Yurdakök M; Ozsoylu S; Kanra T; Durukan T
    Lancet; 1994 Jan; 343(8892):289. PubMed ID: 7905108
    [No Abstract]   [Full Text] [Related]  

  • 30. [Advance in clinical studies of the kinetics of hepatitis B virus].
    Tang YT; Cao Q; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):75-7. PubMed ID: 20128981
    [No Abstract]   [Full Text] [Related]  

  • 31. Age at presentation for infant immunization in Nigeria: implications for hepatitis B immunization.
    Sadoh AE; Eregie CO
    Public Health; 2008 Dec; 122(12):1318-20. PubMed ID: 18706664
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis B: epidemiology and natural history.
    Tran TT; Martin P
    Clin Liver Dis; 2004 May; 8(2):255-66. PubMed ID: 15481339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alarming levels of hepatitis B virus detected among rural Tibetans.
    Clift A; Morgan C; Anderson D; Toole M
    Trop Doct; 2004 Jul; 34(3):156-7. PubMed ID: 15267045
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis B virus seroprevalence among parturients in Accra, Ghana.
    Damale NK; Lassey AT; Bekoe V
    Int J Gynaecol Obstet; 2005 Sep; 90(3):240-1. PubMed ID: 16005878
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiology of hepatitis B in Portugal.
    Silva MJ; Valente J; Capela T; Russo P; Calinas F
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):249-258. PubMed ID: 27861252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased use among GPs of hepatitis B vaccine for priority populations.
    Sheppeard V
    Public Health Res Pract; 2017 Dec; 27(5):. PubMed ID: 31044218
    [No Abstract]   [Full Text] [Related]  

  • 37. [Progress and challenges in achieving the WHO goal on 'Elimination of Hepatitis B by 2030' in China].
    Liu J; Liu M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):605-609. PubMed ID: 31238605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine.
    Poland GA; Jacobson RM
    N Engl J Med; 2004 Dec; 351(27):2832-8. PubMed ID: 15625334
    [No Abstract]   [Full Text] [Related]  

  • 39. [New antivirals for hepatitis B virus infection].
    Nakamoto S; Kanda T; Yokosuka O
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():540-5. PubMed ID: 26845993
    [No Abstract]   [Full Text] [Related]  

  • 40. Achieving ultimate control of hepatitis B infection in China: progress and challenges.
    Jia JD; Yao GB
    J Viral Hepat; 2010 Mar; 17 Suppl 1():2-3. PubMed ID: 20586927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.